Elanco Animal Health Inc (ELAN)

$23.63 -1.08 (-4.37%)
Market Cap 11.80B
Revenue (ttm) 4.72B
Net Income (ttm) -232.00M
EPS (ttm) N/A
PE Ratio 25.21
Forward PE 22.34
Profit Margin -4.92%
Debt to Equity Ratio 0.61
Volume 4,215,200
Avg Vol 5,933,156
Day's Range N/A - N/A
Shares Out 499.45M
Stochastic %K 43%
Beta 1.69
Analysts Strong Sell
Price Target $30.00

Company Profile

Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide. The company offers pet health products, such as parasiticides, vaccines, and therapeutics that protect pets from fleas, ticks, and internal parasites under the Seresto, K-9 Advantage, Advantix, and Advocate trademarks; prescription parasiticide products, an over-the-counter treatments for the prevention and elimination of fleas and ticks under...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 877 352 6261
Address:
450 Elanco Circle, Indianapolis, United States
supplySHOCK
supplySHOCK Jun. 4 at 10:58 AM
$ELAN $ROST $SPY $QQQ tacking
0 · Reply
supplySHOCK
supplySHOCK Jun. 4 at 9:41 AM
$FANG $APTV $MPWR $ELAN thing
0 · Reply
supplySHOCK
supplySHOCK Jun. 4 at 8:07 AM
$ELAN $ROST $KLAC $FAST sense,
0 · Reply
supplySHOCK
supplySHOCK Jun. 3 at 11:23 PM
$APTV $MPWR $ELAN $ROST papers
0 · Reply
Armymike1981
Armymike1981 Jun. 3 at 11:08 PM
$ELAN $ZTS yep
0 · Reply
Cschloegel11
Cschloegel11 Jun. 3 at 5:17 PM
$ELAN screwworm almost to texas…
0 · Reply
TaoistTrader
TaoistTrader May. 25 at 6:23 PM
$ELAN $ZTS $TMDX could be good buys soon
2 · Reply
CEOBuysDisclosures
CEOBuysDisclosures May. 19 at 10:40 PM
$ELAN CEO purchased 4,971 shares at $20.09 for a total of $99,843. Simmons Jeffrey N now owns 2,223,869 shares. https://ceo-buys.com
0 · Reply
TaoistTrader
TaoistTrader May. 19 at 12:01 AM
$ZTS $ELAN beat down but good value 🤔
0 · Reply
swingtraderninja
swingtraderninja May. 16 at 12:12 AM
$ELAN soon ATH. going back to 23.
0 · Reply
Latest News on ELAN
Elanco CEO on rolling out New World screwworm vaccine: 'We're prepared'

Jun 4, 2026, 7:23 PM EDT - 2 days ago

Elanco CEO on rolling out New World screwworm vaccine: 'We're prepared'

Confirmed screwworm case in Texas sends two biotech stocks higher

Jun 4, 2026, 12:57 PM EDT - 2 days ago

Confirmed screwworm case in Texas sends two biotech stocks higher

ZTS

Elanco Animal Health Commits to Supporting U.S. Livestock Producers and Pet Owners in Fight Against New World Screwworm

Jun 4, 2026, 6:26 AM EDT - 3 days ago

Elanco Animal Health Commits to Supporting U.S. Livestock Producers and Pet Owners in Fight Against New World Screwworm

New Research Reveals Pet Spending as a "Protected Budget Item" for Owners, Fueling Industry Resilience

Jun 3, 2026, 7:26 AM EDT - 4 days ago

New Research Reveals Pet Spending as a "Protected Budget Item" for Owners, Fueling Industry Resilience

Elanco Animal Health Transcript: 46th Annual William Blair Growth Stock Conference

Jun 2, 2026, 4:20 PM EDT - 4 days ago

Elanco Animal Health Transcript: 46th Annual William Blair Growth Stock Conference

Elanco Animal Health Transcript: Stifel Jaws & Paws Conference 2026

May 27, 2026, 8:00 AM EDT - 11 days ago

Elanco Animal Health Transcript: Stifel Jaws & Paws Conference 2026

Elanco Animal Health Transcript: AGM 2026

May 21, 2026, 8:00 AM EDT - 17 days ago

Elanco Animal Health Transcript: AGM 2026

Elanco launches Befrena for canine allergic itch

2026-05-18T11:45:28.000Z - 20 days ago

Elanco launches Befrena for canine allergic itch

Elanco Launches Befrena™ (tirnovetmab), New Anti-IL-31 Monoclonal Antibody, a Breakthrough Addition to the $1.3 Billion U.S. Canine Dermatology Market

May 18, 2026, 7:27 AM EDT - 20 days ago

Elanco Launches Befrena™ (tirnovetmab), New Anti-IL-31 Monoclonal Antibody, a Breakthrough Addition to the $1.3 Billion U.S. Canine Dermatology Market

Elanco price target lowered to $23 from $24 at Morgan Stanley

2026-05-15T15:52:34.000Z - 23 days ago

Elanco price target lowered to $23 from $24 at Morgan Stanley

Elanco to Participate in Upcoming Investor Conferences

May 14, 2026, 8:00 AM EDT - 24 days ago

Elanco to Participate in Upcoming Investor Conferences

Elanco price target raised to $30 from $28 at JPMorgan

2026-05-07T15:37:28.000Z - 4 weeks ago

Elanco price target raised to $30 from $28 at JPMorgan

Elanco price target raised to $31 from $30 at Citi

2026-05-07T11:13:56.000Z - 4 weeks ago

Elanco price target raised to $31 from $30 at Citi

Elanco reports Q1 adjusted EPS 40c, consensus 34c

2026-05-07T09:38:45.000Z - 4 weeks ago

Elanco reports Q1 adjusted EPS 40c, consensus 34c

'WE WILL BE PREPARED': Inside efforts to stop screwworm outbreak

May 6, 2026, 4:16 PM EDT - 4 weeks ago

'WE WILL BE PREPARED': Inside efforts to stop screwworm outbreak

Elanco Animal Health Earnings Call Transcript: Q1 2026

May 6, 2026, 8:00 AM EDT - 4 weeks ago

Elanco Animal Health Earnings Call Transcript: Q1 2026

Elanco Animal Health Earnings release: Q1 2026

May 6, 2026, 8:00 AM EDT - 4 weeks ago

Elanco Animal Health Earnings release: Q1 2026

Elanco Animal Health Slides: Q1 2026

May 6, 2026, 8:00 AM EDT - 4 weeks ago

Elanco Animal Health Slides: Q1 2026

Elanco Animal Health Quarterly report: Q1 2026

May 6, 2026, 8:00 AM EDT - 4 weeks ago

Elanco Animal Health Quarterly report: Q1 2026

Elanco Animal Health Reports First Quarter 2026 Results

May 6, 2026, 6:27 AM EDT - 4 weeks ago

Elanco Animal Health Reports First Quarter 2026 Results

Elanco Animal Health Slides: Investor presentation

May 5, 2026, 7:00 AM EDT - 4 weeks ago

Elanco Animal Health Slides: Investor presentation

Elanco's Negasunt™ Powder (Coumaphos, Propoxur, Sulfanilamide Topical Powder) and Tanidil™ (Coumaphos, Propoxur) Receive Emergency Authorization for Use Against New World Screwworm in Livestock

Apr 27, 2026, 6:23 PM EDT - 5 weeks ago

Elanco's Negasunt™ Powder (Coumaphos, Propoxur, Sulfanilamide Topical Powder) and Tanidil™ (Coumaphos, Propoxur) Receive Emergency Authorization for Use Against New World Screwworm in Livestock

Elanco Confirms Date and Conference Call for First Quarter 2026 Financial Results Announcement

Apr 16, 2026, 8:00 AM EDT - 7 weeks ago

Elanco Confirms Date and Conference Call for First Quarter 2026 Financial Results Announcement

Elanco initiated with a Buy at Citi

2026-04-15T10:20:16.000Z - 7 weeks ago

Elanco initiated with a Buy at Citi

Elanco Launches Advantage™ Collar for Dogs with Four Months of Continuous Protection from Fleas, Ticks and Mosquitoes*

Apr 9, 2026, 8:27 AM EDT - 2 months ago

Elanco Launches Advantage™ Collar for Dogs with Four Months of Continuous Protection from Fleas, Ticks and Mosquitoes*

Elanco Animal Health Proxy statement: Proxy filing

Apr 8, 2026, 8:00 AM EDT - 2 months ago

Elanco Animal Health Proxy statement: Proxy filing

Elanco Animal Health Proxy statement: Proxy filing

Apr 8, 2026, 8:00 AM EDT - 2 months ago

Elanco Animal Health Proxy statement: Proxy filing

Elanco Animal Health Transcript: 2026 KeyBanc Capital Markets Healthcare Forum

Mar 17, 2026, 9:00 AM EDT - 2 months ago

Elanco Animal Health Transcript: 2026 KeyBanc Capital Markets Healthcare Forum

Elanco Animal Health Transcript: Leerink Global Healthcare Conference 2026

Mar 11, 2026, 10:40 AM EDT - 3 months ago

Elanco Animal Health Transcript: Leerink Global Healthcare Conference 2026

Elanco Animal Health Transcript: Barclays 28th Annual Global Healthcare Conference

Mar 10, 2026, 11:30 AM EDT - 3 months ago

Elanco Animal Health Transcript: Barclays 28th Annual Global Healthcare Conference

Elanco Animal Health Transcript: TD Cowen 46th Annual Health Care Conference

Mar 2, 2026, 2:30 PM EST - 3 months ago

Elanco Animal Health Transcript: TD Cowen 46th Annual Health Care Conference

Elanco Animal Health Slides: Investor presentation

Mar 2, 2026, 6:00 AM EST - 3 months ago

Elanco Animal Health Slides: Investor presentation

Elanco price target raised to $32 from $30 at Stifel

2026-02-27T13:04:51.000Z - 3 months ago

Elanco price target raised to $32 from $30 at Stifel

Oil-Dri Corporation of America, Elanco partner on Japan calf health seminars

2026-02-26T22:25:58.000Z - 3 months ago

Oil-Dri Corporation of America, Elanco partner on Japan calf health seminars

ODC

Elanco Animal Health Transcript: BofA Securities Animal Health Summit

Feb 26, 2026, 11:35 AM EST - 3 months ago

Elanco Animal Health Transcript: BofA Securities Animal Health Summit

Elanco price target raised to $31 from $30 at UBS

2026-02-26T13:16:37.000Z - 3 months ago

Elanco price target raised to $31 from $30 at UBS

Elanco price target raised to $30 from $28 at BofA

2026-02-25T14:30:51.000Z - 3 months ago

Elanco price target raised to $30 from $28 at BofA

Elanco price target raised to $30 from $27 at Stifel

2026-02-25T13:03:11.000Z - 3 months ago

Elanco price target raised to $30 from $27 at Stifel

Elanco price target raised to $29 from $27 at KeyBanc

2026-02-25T12:24:52.000Z - 3 months ago

Elanco price target raised to $29 from $27 at KeyBanc

Elanco CEO: We’ve transitioned into a sustainable growth company

2026-02-24T23:50:18.000Z - 3 months ago

Elanco CEO: We’ve transitioned into a sustainable growth company

Elanco price target raised to $30 from $26 at Leerink

2026-02-24T19:55:16.000Z - 3 months ago

Elanco price target raised to $30 from $26 at Leerink

Elanco Animal Health Earnings Call Transcript: Q4 2025

Feb 24, 2026, 8:00 AM EST - 3 months ago

Elanco Animal Health Earnings Call Transcript: Q4 2025

Elanco Animal Health Annual report: Q4 2025

Feb 24, 2026, 8:00 AM EST - 3 months ago

Elanco Animal Health Annual report: Q4 2025

Elanco Animal Health Earnings release: Q4 2025

Feb 24, 2026, 8:00 AM EST - 3 months ago

Elanco Animal Health Earnings release: Q4 2025

Elanco Animal Health Slides: Q4 2025

Feb 24, 2026, 8:00 AM EST - 3 months ago

Elanco Animal Health Slides: Q4 2025

Elanco reports Q4 adjusted EPS 13c, consensus 11c

2026-02-24T11:38:23.000Z - 3 months ago

Elanco reports Q4 adjusted EPS 13c, consensus 11c

Elanco Animal Health Slides: Investor presentation

Feb 24, 2026, 6:30 AM EST - 3 months ago

Elanco Animal Health Slides: Investor presentation

Elanco Animal Health Reports Fourth Quarter and Full Year 2025 Results

Feb 24, 2026, 6:27 AM EST - 3 months ago

Elanco Animal Health Reports Fourth Quarter and Full Year 2025 Results

Notable companies reporting before tomorrow’s open

2026-02-23T19:25:25.000Z - 3 months ago

Notable companies reporting before tomorrow’s open

AS DOCN HD HSIC KDP PLNT

Elanco Announces Updates to Board of Directors

Feb 13, 2026, 9:24 AM EST - 4 months ago

Elanco Announces Updates to Board of Directors

Elanco Confirms Date and Conference Call for Fourth Quarter and Full Year 2025 Financial Results Announcement

Jan 22, 2026, 8:00 AM EST - 4 months ago

Elanco Confirms Date and Conference Call for Fourth Quarter and Full Year 2025 Financial Results Announcement

Elanco Animal Health Transcript: 44th Annual J.P. Morgan Healthcare Conference

Jan 13, 2026, 6:45 PM EST - 5 months ago

Elanco Animal Health Transcript: 44th Annual J.P. Morgan Healthcare Conference

Elanco Animal Health Slides: 44th Annual J.P. Morgan Healthcare Conference

Jan 13, 2026, 6:45 PM EST - 5 months ago

Elanco Animal Health Slides: 44th Annual J.P. Morgan Healthcare Conference

Elanco to Participate in the 44th Annual J.P. Morgan Healthcare Conference

Jan 6, 2026, 8:00 AM EST - 5 months ago

Elanco to Participate in the 44th Annual J.P. Morgan Healthcare Conference

Elanco Receives USDA Approval for Befrena™ (tirnovetmab), a New Anti-IL31 Monoclonal Antibody Injection Targeting Canine Allergic and Atopic Dermatitis

Dec 31, 2025, 2:00 PM EST - 5 months ago

Elanco Receives USDA Approval for Befrena™ (tirnovetmab), a New Anti-IL31 Monoclonal Antibody Injection Targeting Canine Allergic and Atopic Dermatitis

Elanco's Credelio Quattro™-CA1 (lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets) Receives First FDA Conditional Approval for Treatment of New World Screwworm in Dogs

Dec 18, 2025, 8:43 AM EST - 6 months ago

Elanco's Credelio Quattro™-CA1 (lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets) Receives First FDA Conditional Approval for Treatment of New World Screwworm in Dogs

Elanco Animal Health Transcript: Investor Day 2025

Dec 9, 2025, 9:00 AM EST - 6 months ago

Elanco Animal Health Transcript: Investor Day 2025

Elanco Animal Health Slides: FY 2025

Dec 9, 2025, 9:00 AM EST - 6 months ago

Elanco Animal Health Slides: FY 2025

Elanco Investor Day Defines New Era as Sustainable Growth Company

Dec 9, 2025, 7:40 AM EST - 6 months ago

Elanco Investor Day Defines New Era as Sustainable Growth Company

Elanco Animal Health Transcript: Piper Sandler 37th Annual Healthcare Conference

Dec 4, 2025, 8:30 AM EST - 6 months ago

Elanco Animal Health Transcript: Piper Sandler 37th Annual Healthcare Conference

Elanco Animal Health Transcript: Evercore ISI 8th Annual HealthCONx Conference

Dec 3, 2025, 12:30 PM EST - 6 months ago

Elanco Animal Health Transcript: Evercore ISI 8th Annual HealthCONx Conference

Elanco executive appointed as Neurizon's Board Observer

Nov 26, 2025, 6:15 PM EST - 6 months ago

Elanco executive appointed as Neurizon's Board Observer

Elanco's drug gets emergency nod to treat deadly flesh-eating parasite in cats

Nov 21, 2025, 2:18 PM EST - 7 months ago

Elanco's drug gets emergency nod to treat deadly flesh-eating parasite in cats

Elanco's Credelio™ CAT (lotilaner) Receives First FDA Emergency Use Authorization (EUA) for Treatment of New World Screwworm (NWS) in Cats

Nov 21, 2025, 1:35 PM EST - 7 months ago

Elanco's Credelio™ CAT (lotilaner) Receives First FDA Emergency Use Authorization (EUA) for Treatment of New World Screwworm (NWS) in Cats

Elanco to Participate in the Upcoming Investor Conferences

Nov 20, 2025, 8:00 AM EST - 7 months ago

Elanco to Participate in the Upcoming Investor Conferences

Alloy Partners Launches OneHealth Studio to Create Startups at the Convergence of Animal, Plant and Human Health

Nov 13, 2025, 8:00 AM EST - 7 months ago

Alloy Partners Launches OneHealth Studio to Create Startups at the Convergence of Animal, Plant and Human Health

Elanco Animal Health CEO: Seeing a willingness to spend, durability even in 'consumer tested' time

Nov 5, 2025, 2:43 PM EST - 7 months ago

Elanco Animal Health CEO: Seeing a willingness to spend, durability even in 'consumer tested' time

Elanco Animal Health Earnings Call Transcript: Q3 2025

Nov 5, 2025, 8:00 AM EST - 7 months ago

Elanco Animal Health Earnings Call Transcript: Q3 2025

Elanco Animal Health Quarterly report: Q3 2025

Nov 5, 2025, 8:00 AM EST - 7 months ago

Elanco Animal Health Quarterly report: Q3 2025

Elanco Animal Health Earnings release: Q3 2025

Nov 5, 2025, 8:00 AM EST - 7 months ago

Elanco Animal Health Earnings release: Q3 2025

Elanco Animal Health Slides: Q3 2025

Nov 5, 2025, 8:00 AM EST - 7 months ago

Elanco Animal Health Slides: Q3 2025

Elanco Animal Health Reports Third Quarter 2025 Results

Nov 5, 2025, 6:27 AM EST - 7 months ago

Elanco Animal Health Reports Third Quarter 2025 Results

Elanco Announces Expansion of Credelio Quattro™ (lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets) and Credelio™ (lotilaner) Labels, Offering Protection Against Lyme Disease and an Emerging Tick Species

Oct 27, 2025, 6:27 AM EDT - 7 months ago

Elanco Announces Expansion of Credelio Quattro™ (lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets) and Credelio™ (lotilaner) Labels, Offering Protection Against Lyme Disease and an Emerging Tick Species

Elanco gets US FDA emergency nod for dog drug as threat of flesh-eating parasite looms

Oct 24, 2025, 6:10 PM EDT - 8 months ago

Elanco gets US FDA emergency nod for dog drug as threat of flesh-eating parasite looms

Elanco Animal Health Obtains FDA Authorization for Screwworm Treatment

Oct 24, 2025, 5:33 PM EDT - 8 months ago

Elanco Animal Health Obtains FDA Authorization for Screwworm Treatment

Elanco's Credelio™ (lotilaner) Receives First Ever FDA Emergency Use Authorization (EUA) against New World Screwworm (NWS) in Dogs

Oct 24, 2025, 4:55 PM EDT - 8 months ago

Elanco's Credelio™ (lotilaner) Receives First Ever FDA Emergency Use Authorization (EUA) against New World Screwworm (NWS) in Dogs

Elanco to Host Investor Day on December 9

Oct 16, 2025, 4:32 PM EDT - 8 months ago

Elanco to Host Investor Day on December 9

Elanco Confirms Date and Conference Call for Third Quarter 2025 Financial Results Announcement

Oct 1, 2025, 8:00 AM EDT - 8 months ago

Elanco Confirms Date and Conference Call for Third Quarter 2025 Financial Results Announcement

Elanco Announces FDA Approves Improved Zenrelia™ (ilunocitinib tablets) Label, Removing Vaccine-Induced Disease Language

Sep 23, 2025, 6:27 AM EDT - 9 months ago

Elanco Announces FDA Approves Improved Zenrelia™ (ilunocitinib tablets) Label, Removing Vaccine-Induced Disease Language

Elanco Animal Health Transcript: Morgan Stanley 23rd Annual Global Healthcare Conference

Sep 9, 2025, 8:30 AM EDT - 9 months ago

Elanco Animal Health Transcript: Morgan Stanley 23rd Annual Global Healthcare Conference

Elanco Innovation Builds Momentum, Credelio Quattro™ (lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets) Reaches Blockbuster Status

Sep 8, 2025, 6:27 AM EDT - 9 months ago

Elanco Innovation Builds Momentum, Credelio Quattro™ (lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets) Reaches Blockbuster Status

Splenda® Joins Elanco and HATCH to Support 'Nutrition Secure Indianapolis' to Strengthen Family Health Through Nutrition and Education

Aug 27, 2025, 8:00 AM EDT - 10 months ago

Splenda® Joins Elanco and HATCH to Support 'Nutrition Secure Indianapolis' to Strengthen Family Health Through Nutrition and Education

Elanco Animal Health Set to Join S&P MidCap 400; Sarepta Therapeutics to Join S&P SmallCap 600

Aug 26, 2025, 6:15 PM EDT - 10 months ago

Elanco Animal Health Set to Join S&P MidCap 400; Sarepta Therapeutics to Join S&P SmallCap 600

BBT BRKL

Elanco to Participate in Morgan Stanley 23rd Annual Global Healthcare Conference

Aug 26, 2025, 8:00 AM EDT - 10 months ago

Elanco to Participate in Morgan Stanley 23rd Annual Global Healthcare Conference

Elanco Animal Health Earnings Call Transcript: Q2 2025

Aug 7, 2025, 8:00 AM EDT - 10 months ago

Elanco Animal Health Earnings Call Transcript: Q2 2025

Elanco Animal Health Quarterly report: Q2 2025

Aug 7, 2025, 8:00 AM EDT - 10 months ago

Elanco Animal Health Quarterly report: Q2 2025

Elanco Animal Health Earnings release: Q2 2025

Aug 7, 2025, 8:00 AM EDT - 10 months ago

Elanco Animal Health Earnings release: Q2 2025

Elanco Animal Health Slides: Q2 2025

Aug 7, 2025, 8:00 AM EDT - 10 months ago

Elanco Animal Health Slides: Q2 2025

Elanco Animal Health Reports Second Quarter 2025 Results

Aug 7, 2025, 6:27 AM EDT - 10 months ago

Elanco Animal Health Reports Second Quarter 2025 Results

Elanco Secures Approval of Zenrelia™ (ilunocitinib) in the European Union (EU), Launching Innovative Canine Dermatology Treatment for Itchy Dogs

Jul 24, 2025, 5:42 PM EDT - 11 months ago

Elanco Secures Approval of Zenrelia™ (ilunocitinib) in the European Union (EU), Launching Innovative Canine Dermatology Treatment for Itchy Dogs

Elanco Confirms Date and Conference Call for Second Quarter 2025 Financial Results Announcement

Jul 10, 2025, 8:00 AM EDT - 11 months ago

Elanco Confirms Date and Conference Call for Second Quarter 2025 Financial Results Announcement

Elanco's dog flu vaccine gets USDA nod

Jul 9, 2025, 10:01 AM EDT - 11 months ago

Elanco's dog flu vaccine gets USDA nod

Elanco Receives USDA Approval for TruCan™ Ultra CIV H3N2/H3N8 (Canine Influenza Vaccine) Bringing to Market a High Standard of Respiratory Protection

Jul 9, 2025, 8:27 AM EDT - 11 months ago

Elanco Receives USDA Approval for TruCan™ Ultra CIV H3N2/H3N8 (Canine Influenza Vaccine) Bringing to Market a High Standard of Respiratory Protection

Neurizon Enters into Global License with Elanco to Accelerate Commercialisation of NUZ-001

Jul 2, 2025, 7:09 PM EDT - 1 year ago

Neurizon Enters into Global License with Elanco to Accelerate Commercialisation of NUZ-001

Elanco Releases 2024 Impact Report and Introduces New Framework

Jun 26, 2025, 1:00 PM EDT - 1 year ago

Elanco Releases 2024 Impact Report and Introduces New Framework

Elanco Receives Positive Opinion on Zenrelia (ilunocitinib) from EU's Committee for Veterinary Medicinal Products (CVMP)

Jun 12, 2025, 4:17 PM EDT - 1 year ago

Elanco Receives Positive Opinion on Zenrelia (ilunocitinib) from EU's Committee for Veterinary Medicinal Products (CVMP)

Elanco Releases New Report Highlighting the Significance of America's Itchy Dogs and the Need for Itch Relief

Jun 5, 2025, 7:45 AM EDT - 1 year ago

Elanco Releases New Report Highlighting the Significance of America's Itchy Dogs and the Need for Itch Relief

Elanco Animal Health Transcript: Stifel Jaws & Paws Conference 2025

May 29, 2025, 8:00 AM EDT - 1 year ago

Elanco Animal Health Transcript: Stifel Jaws & Paws Conference 2025

Elanco Appoints Robert (Bob) VanHimbergen as Chief Financial Officer

May 28, 2025, 7:25 AM EDT - 1 year ago

Elanco Appoints Robert (Bob) VanHimbergen as Chief Financial Officer

Elanco Animal Health Slides: Investor Presentation

May 27, 2025, 7:00 AM EDT - 1 year ago

Elanco Animal Health Slides: Investor Presentation

Elanco Animal Health Transcript: BNP Paribas 2nd Annual Animal Health Day

May 22, 2025, 12:00 PM EDT - 1 year ago

Elanco Animal Health Transcript: BNP Paribas 2nd Annual Animal Health Day

Elanco Animal Health Earnings Call Transcript: Q1 2025

May 7, 2025, 8:00 AM EDT - 1 year ago

Elanco Animal Health Earnings Call Transcript: Q1 2025

Elanco Animal Health Quarterly report: Q1 2025

May 7, 2025, 8:00 AM EDT - 1 year ago

Elanco Animal Health Quarterly report: Q1 2025

Elanco Animal Health Earnings release: Q1 2025

May 7, 2025, 8:00 AM EDT - 1 year ago

Elanco Animal Health Earnings release: Q1 2025

Elanco Animal Health Slides: Q1 2025

May 7, 2025, 8:00 AM EDT - 1 year ago

Elanco Animal Health Slides: Q1 2025

Elanco Animal Health Reports First Quarter 2025 Results

May 7, 2025, 6:27 AM EDT - 1 year ago

Elanco Animal Health Reports First Quarter 2025 Results

Elanco Sells Royalty and Milestone Rights for Lotilaner in Human Health to Blackstone; Accelerates Debt Paydown

May 5, 2025, 6:27 AM EDT - 1 year ago

Elanco Sells Royalty and Milestone Rights for Lotilaner in Human Health to Blackstone; Accelerates Debt Paydown

TARS

supplySHOCK
supplySHOCK Jun. 4 at 10:58 AM
$ELAN $ROST $SPY $QQQ tacking
0 · Reply
supplySHOCK
supplySHOCK Jun. 4 at 9:41 AM
$FANG $APTV $MPWR $ELAN thing
0 · Reply
supplySHOCK
supplySHOCK Jun. 4 at 8:07 AM
$ELAN $ROST $KLAC $FAST sense,
0 · Reply
supplySHOCK
supplySHOCK Jun. 3 at 11:23 PM
$APTV $MPWR $ELAN $ROST papers
0 · Reply
Armymike1981
Armymike1981 Jun. 3 at 11:08 PM
$ELAN $ZTS yep
0 · Reply
Cschloegel11
Cschloegel11 Jun. 3 at 5:17 PM
$ELAN screwworm almost to texas…
0 · Reply
TaoistTrader
TaoistTrader May. 25 at 6:23 PM
$ELAN $ZTS $TMDX could be good buys soon
2 · Reply
CEOBuysDisclosures
CEOBuysDisclosures May. 19 at 10:40 PM
$ELAN CEO purchased 4,971 shares at $20.09 for a total of $99,843. Simmons Jeffrey N now owns 2,223,869 shares. https://ceo-buys.com
0 · Reply
TaoistTrader
TaoistTrader May. 19 at 12:01 AM
$ZTS $ELAN beat down but good value 🤔
0 · Reply
swingtraderninja
swingtraderninja May. 16 at 12:12 AM
$ELAN soon ATH. going back to 23.
0 · Reply
Bogeymakr
Bogeymakr May. 15 at 3:27 PM
$ELAN A little surprised that this looks like heading back to 20. 🤷‍♂️
0 · Reply
MyChicago
MyChicago May. 13 at 4:02 PM
$ZOMDF Zomedica May Momentum CEO Larry Heaton and Johnny D Powers, both added shares in May 2026, direct insider confidence right after Zomedica reported record Q1 revenue of $8.8 million, up 35% YoY with $47.5 million in liquidity. Insiders don’t buy unless they believe in the next leg up. $IDXX $AMZN $ELAN
2 · Reply
CapitalMonk
CapitalMonk May. 12 at 10:40 AM
$ELAN Price: $21.72 (-8.16%) Trend: Bullish Market Bias (7D): Bullish Bias 📈 Expected Range: ±0.92% RSI: 45.8 | Momentum: Moderate Volume: +49.5% vs avg Volatility: 4.55% Support: $21.62 | Resistance: $26.29 Tools used: https://www.trade-ideas.com Code: INTERSTOCK25
0 · Reply
Estimize
Estimize May. 12 at 10:00 AM
Wall St is expecting 0.27 EPS for $ELAN Q2 [Reporting 08/10 BMO] http://www.estimize.com/intro/elan?chart=historical&metric_name=eps&utm_co
0 · Reply
MarketBeat
MarketBeat May. 10 at 7:10 AM
https://marketbeat.com/a/8644832/ $ELAN Elanco Animal Health Q1 Earnings Call Highlights
0 · Reply
Armymike1981
Armymike1981 May. 8 at 8:14 PM
$CHWY buy!!!! $ELAN had great earnings and is gonna surpass old Zoetis!!! The reason the animal industry is down because of Zoetis …. Not because the industry is bad but because their drugs aren’t selling due to much better products from Companies like Elanco and Merck …. Buy calls or shares in chwy or elan and you will not be disappointed $ZTS sucks!!!
1 · Reply
Jblack500
Jblack500 May. 8 at 3:59 PM
$ANIP $GILD $ELAN $ARWR $ABVX who bought the dip..I know I did...current pt is near 110 and will see pt increases on this q and guidance
0 · Reply
Jblack500
Jblack500 May. 8 at 1:55 PM
$ANIP $GILD $ELAN $ARWR $ABVX anip pullback on these earnings is a gift and should be bought
0 · Reply
Jblack500
Jblack500 May. 8 at 11:59 AM
$ANIP $ABVX $ARWR $GILD $ELAN anip earnings were excellent
0 · Reply
DonCorleone77
DonCorleone77 May. 7 at 9:11 PM
$ELAN Attached is a Citi analyst note regarding ELAN issued today.
0 · Reply
RMAW
RMAW May. 7 at 1:35 PM
$ELAN Fuck YOU $ZTS !!!!
0 · Reply
Armymike1981
Armymike1981 May. 7 at 1:17 PM
$ELAN $ZTS …. Said this two years ago!!! Yall should listen to vets on this one!!! Elan has a large move to make and Zoetis is done !!! The FDA came back and said Zenerelia is safe!!’
0 · Reply